171 related articles for article (PubMed ID: 11769451)
1. [Efficiency of high-flow dialyzers in removal of beta-2-microglobulin].
Leto E; Bilal F; Osmic I
Med Arh; 2001; 55(4):225-6. PubMed ID: 11769451
[TBL] [Abstract][Full Text] [Related]
2. The effect of hollow-fiber dialyzer Plivadial Altra-Flux 140 on beta-2-microglobulin removal.
Kes P; Zubcić A; Ratković-Gusić I; Prsa M; Sefer S
Acta Med Croatica; 1997; 51(2):105-9. PubMed ID: 9204596
[TBL] [Abstract][Full Text] [Related]
3. Determinants of plasma beta 2 microglobulin concentration: possible relation to membrane biocompatibility.
Bommer J; Seelig P; Seelig R; Geerlings W; Bommer G; Ritz E
Nephrol Dial Transplant; 1987; 2(1):22-5. PubMed ID: 3110692
[TBL] [Abstract][Full Text] [Related]
4. The effects of reprocessing cuprophane and polysulfone dialyzers on beta 2-microglobulin removal from hemodialysis patients.
Petersen J; Moore RM; Kaczmarek RG; Singh B; Yeh I; Hamburger S; Kankam M
Am J Kidney Dis; 1991 Feb; 17(2):174-8. PubMed ID: 1992659
[TBL] [Abstract][Full Text] [Related]
5. Effect of dialyzer membranes on beta-2 microglobulin production in Thai hemodialysis patients.
Domrongkitchaiporn S; Chuncharunee S; Archararit N; Atamasirikul K; Vanichakarn S
J Med Assoc Thai; 1997 Sep; 80 Suppl 1():S138-43. PubMed ID: 9347661
[TBL] [Abstract][Full Text] [Related]
6. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
Lovcić V; Kes P; Zeljko R; Kusec V
Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
[TBL] [Abstract][Full Text] [Related]
7. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study.
Traut M; Haufe CC; Eismann U; Deppisch RM; Stein G; Wolf G
Blood Purif; 2007; 25(5-6):432-40. PubMed ID: 17957097
[TBL] [Abstract][Full Text] [Related]
8. Clinical evaluation of four different high-flux hemodialyzers under conventional conditions in vivo.
Sombolos K; Tsitamidou Z; Kyriazis G; Karagianni A; Kantaropoulou M; Progia E
Am J Nephrol; 1997; 17(5):406-12. PubMed ID: 9382156
[TBL] [Abstract][Full Text] [Related]
9. Beta 2-microglobulin kinetics in maintenance hemodialysis: a comparison of conventional and high-flux dialyzers and the effects of dialyzer reuse.
DiRaimondo CR; Pollak VE
Am J Kidney Dis; 1989 May; 13(5):390-5. PubMed ID: 2655439
[TBL] [Abstract][Full Text] [Related]
10. Intradialytic body weight changes and dialyzer pore size as main contributing factors to the evolution of beta-2-microglobulin in dialysis.
Vanholder RC; Ringoir SM
Blood Purif; 1990; 8(1):32-44. PubMed ID: 2198890
[TBL] [Abstract][Full Text] [Related]
11. Factors affecting beta 2-microglobulin plasma concentration during hemodialysis.
Martin-Malo A; Mallol J; Castillo D; Barrio V; Burdiel LG; Perez R; Aljama P
Int J Artif Organs; 1989 Aug; 12(8):509-14. PubMed ID: 2681000
[TBL] [Abstract][Full Text] [Related]
12. Effect of formaldehyde/bleach reprocessing on in vivo performances of high-efficiency cellulose and high-flux polysulfone dialyzers.
Murthy BV; Sundaram S; Jaber BL; Perrella C; Meyer KB; Pereira BJ
J Am Soc Nephrol; 1998 Mar; 9(3):464-72. PubMed ID: 9513910
[TBL] [Abstract][Full Text] [Related]
13. Serum beta 2-microglobulin concentration in dialysis patients: importance of intrinsic renal function.
McCarthy JT; Williams AW; Johnson WJ
J Lab Clin Med; 1994 Apr; 123(4):495-505. PubMed ID: 8144998
[TBL] [Abstract][Full Text] [Related]
14. [Cystatin C, beta2-microglobulin and C-reactive protein in hemodiafiltration and on-line endogenous liquid reinfusion and in low flux polysulphone bicarbonate conventional hemodialysis].
Cristofano C; Vernaglione L; Perniola MA; Lo Barco C; Muscogiuri P; Chimienti S
G Ital Nefrol; 2004; 21 Suppl 30():S197-200. PubMed ID: 15750984
[TBL] [Abstract][Full Text] [Related]
15. Biocompatibility and performance of a modified cellulosic and a synthetic high flux dialyzer. A randomized crossover comparison between cellulose triacetate and polysulphon.
Grooteman MP; Nubé MJ; van Limbeek J; van Houte AJ; Daha MR; van Geelen JA
ASAIO J; 1995; 41(2):215-20. PubMed ID: 7640431
[TBL] [Abstract][Full Text] [Related]
16. [Behavior of beta 2-microglobulin in patients undergoing blood purification].
Hou FF
Zhonghua Nei Ke Za Zhi; 1990 Jun; 29(6):353-6, 383. PubMed ID: 2269036
[TBL] [Abstract][Full Text] [Related]
17. Relationship between serum beta 2-microglobulin, bone histology, and dialysis membranes in uraemic patients.
Ferreira A; Ureña P; Ang KS; Simon P; Morieux C; Souberbielle JC; de Vernejoul MC; Drüeke TB
Nephrol Dial Transplant; 1995; 10(9):1701-7. PubMed ID: 8559492
[TBL] [Abstract][Full Text] [Related]
18. Beta-2-microglobulin in hemodialysis patients. Effects of different dialyzers and different dialysis procedures.
Mayer G; Thum J; Woloszczuk W; Graf H
Am J Nephrol; 1988; 8(4):280-4. PubMed ID: 3055992
[TBL] [Abstract][Full Text] [Related]
19. Beta 2-microglobulin kinetics during haemodialysis and haemofiltration.
Flöge J; Granolleras C; Bingel M; Deschodt G; Branger B; Oules R; Koch KM; Shaldon S
Nephrol Dial Transplant; 1987; 1(4):223-8. PubMed ID: 3110678
[TBL] [Abstract][Full Text] [Related]
20. Cystatin C: a new marker of biocompatibility or a good marker for the redistribution of LMW proteins during hemodialysis?
Thysell H; Grubb A; Lindholm T; Ljunggren L; Mårtensson L
ASAIO Trans; 1988; 34(3):202-4. PubMed ID: 3058174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
